Center for Neurologic Research

Lethbridge, Alberta T1J0N9

2 studies enrolling now · 6 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Diabetes, Focal Epilepsy, Focal Onset Seizures, Heart Disease, High-risk Transient Ischemic Attack, Ischemic Heart Disease, Myocardial Infarction, Prevention of Ischemic Stroke, Primary Generalized Tonic-Clonic Seizures, Stroke, Tonic-Clonic Seizures

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Completed